2012  |  2011  |  2010  |  2009  |  2008  |  2007  |  2006–2004  |   Download a list of references.

1. Coordinated regulation of mitochondrial topoisomerase IB with mitochondrial nuclear encoded genes and MYC.
   Zoppoli G, Douarre C, Dalla Rosa I, Liu H, Reinhold W, Pommier Y.
   Nucleic Acids Res. 2011 Aug;39(15):6620-32. Pubmed
2. Inhibition of the Single Downstream Target BAG1 Activates the Latent Apoptotic Potential of MYC
   Zhang XY, Pfeiffer HK, Mellert HS, Stanek TJ, Sussman RT, Kumari A, Yu D, Rigoutsos I, Thomas-Tikhonenko A, Seidel HE, Chodosh LA, Packham G, Baserga R, McMahon SB.
   Mol Cell Biol. 2011 Dec;31(24):5037-45. Pubmed
3. Targeting 14-3-3zeta in cancer therapy.
   Yang X, Cao W, Zhang L, Zhang W, Zhang X, Lin H.
   Cancer Gene Ther. 2011 Dec 23. Pubmed
4. Cyclophilin B Expression Is Associated with In Vitro Radioresistance and Clinical Outcome after Radiotherapy
   Williams PD, Owens CR, Dziegielewski J, Moskaluk CA, Read PW, Larner JM, Story MD, Brock WA, Amundson SA, Lee JK, Theodorescu D.
   Neoplasia. 2011 Dec;13(12):1122-31. Pubmed
5. Transfer RNA Methytransferases and Their Corresponding Modifications in Budding Yeast and Humans: Activities, Predications, and Potential Roles in Human Health.
   Towns WL, Begley TJ.
   DNA Cell Biol. 2011 Dec 22. Pubmed
6. Membrane-type-3 matrix metalloproteinase (MT3-MMP) functions as a matrix composition-dependent effector of melanoma cell invasion.
   Tatti O, Arjama M, Ranki A, Weiss SJ, Keski-Oja J, Lehti K.
   PLoS One. 2011;6(12):e28325. Pubmed
7. p53-Responsive miR-194 Inhibits Thrombospondin-1 and Promotes Angiogenesis in Colon Cancers
   Sundaram P, Hultine S, Smith LM, Dews M, Fox JL, Biyashev D, Schelter JM, Huang Q, Cleary MA, Volpert OV, Thomas-Tikhonenko A.
   Cancer Res. 2011 Dec 15;71(24):7490-501. Pubmed
8. Radioresistance and Cancer Stem Cells: Survival of the Fittest
   Sun L, Cabarcas SM, Farrar, WL
   J Carcinogene Mutagene 2011
9. Serine/threonine protein phosphatase 6 modulates the radiation sensitivity of glioblastoma.
   Shen Y, Wang Y, Sheng K, Fei X, Guo Q, Larner J, Kong X, Qiu Y, Mi J.
   Cell Death Dis. 2011 Dec 8;2:e241 Pubmed
10. Entopic overexpression of Ascl2 does not accelerate tumourigenesis in ApcMin mice.
    Reed KR, Tunster SJ, Young M, Carrico A, John RM, Clarke AR.
    Gut. 2011 Dec 3. Pubmed
11. Zebrafish as a Model to Characterize TEL2 Function During Development and Cancer
    Quintana AM, Grosveld, GC
    J Carcinogene Mutagene
12. Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression
    Putluri N, Shojaie A, Vasu VT, Vareed SK, Nalluri S, Putluri V, Thangjam GS, Panzitt K, Tallman CT, Butler C, Sana TR, Fischer SM, Sica G, Brat DJ, Shi H, Palapattu GS, Lotan Y, Weizer AZ, Terris MK, Shariat SF, Michailidis G, Sreekumar A.
    Cancer Res. 2011 Dec 15;71(24):7376-86. Pubmed
13. p27(Kip1) represses transcription by direct interaction with p130/E2F4 at the promoters of target genes.
    Pippa R, Espinosa L, Gundem G, García-Escudero R, Dominguez A, Orlando S, Gallastegui E, Saiz C, Besson A, Pujol MJ, López-Bigas N, Paramio JM, Bigas A, Bachs O.
    Oncogene. 2011 Dec 19. Pubmed
14. Inhibitor of DNA-binding 4 contributes to the maintenance and expansion of cancer stem cells in 4T1 mouse mammary cancer cell line.
    Park SJ, Kim RJ, Nam JS.
    Lab Anim Res. 2011 Dec;27(4):333-8. Pubmed
15. ATP synthase ecto-alpha-subunit: a novel therapeutic target for breast cancer
    Pan J, Sun LC, Tao YF, Zhou Z, Du XL, Peng L, Feng X, Wang J, Li YP, Liu L, Wu SY, Zhang YL, Hu SY, Zhao WL, Zhu XM, Lou GL, Ni J.
    J Transl Med. 2011 Dec 8;9:211. Pubmed
16. Digital gene expression profiling of primary acute lymphoblastic leukemia cells
    Nordlund J, Kiialainen A, Karlberg O, Berglund EC, Göransson-Kultima H, Sønderkær M, Nielsen KL, Gustafsson MG, Behrendtz M, Forestier E, Perkkiö M, Söderhäll S, Lönnerholm G, Syvänen AC.
    Leukemia. 2011 Dec 16. Pubmed
17. Key pathways involved in prostate cancer based on gene set enrichment analysis and meta analysis.
    Ning QY, Wu JZ, Zang N, Liang J, Hu YL, Mo ZN.
    Genet Mol Res. 2011 Dec 14;10(4). Pubmed
18. Cediranib inhibits both the intraosseous growth of PDGF D-Positive prostate cancer cells and the associated bone reaction.
    Najy AJ, Jung YS, Won JJ, Conley-Lacomb MK, Saliganan A, Kim CJ, Heath E, Cher ML, Bonfil RD, Kim HR.
    Prostate. 2011 Dec 27. Pubmed
19. Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model.
    Matoka DJ, Yao V, Harya DS, Gregg JL, Robinson AR, Niedernhofer LJ, Parwani AV, Maier C, Bacich DJ.
    Prostate. 2011 Dec 27. Pubmed
20. Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
    Li M, Mukasa A, del-Mar Inda M, Zhang J, Chin L, Cavenee W, Furnari F.
    J Exp Med. 2011 Dec 19;208(13):2657-73. Pubmed
21. New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats
    Laurent FX, Sureau A, Klein AF, Trouslard F, Gasnier E, Furling D, Marie J.
    Nucleic Acids Res. 2011 Dec 9. Pubmed
22. Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis.
    Kosa P, Szabo R, Molinolo AA, Bugge TH.
    Oncogene. 2011 Dec 5. Pubmed
23. Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.
    Hernandez L, Magalhaes MA, Coniglio SJ, Condeelis JS, Segall JE.
    Breast Cancer Res. 2011 Dec 9;13(6):R128. Pubmed
24. Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker.
    Hao Z, Zhang H, Cowell J.
    Tumour Biol. 2011 Dec 16. Pubmed
25. Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells.
    Cho S, Lu M, He X, Ee PL, Bhat U, Schneider E, Miele L, Beck WT.
    Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20778-83. Pubmed
26. The Discovery of Putative Urine Markers for the Specific Detection of Prostate Tumor by Integrative Mining of Public Genomic Profiles
    Chen M, Wang K, Zhang L, Li C, Yang Y.
    PLoS One. 2011;6(12):e28552. Pubmed
27. Dnmt3a is essential for hematopoietic stem cell differentiation.
    Challen GA, Sun D, Jeong M, Luo M, Jelinek J, Berg JS, Bock C, Vasanthakumar A, Gu H, Xi Y, Liang S, Lu Y, Darlington GJ, Meissner A, Issa JP, Godley LA, Li W, Goodell MA.
    Nat Genet. 2011 Dec 4;44(1):23-31. Pubmed
28. Transcriptional activity of ATF3 in the stromal compartment of tumors promotes cancer progression
    Buganim, Y; Madar, S; Rais, Y; Pomeraniec, L; Harel, E; Solomon, H; Kalo, E; Goldstein, I; Brosh, R; Haimov, O; Avivi, C; Polak-Charcon, S; Goldfinger, N; Barshack, I; Rotter, V
    Carcinogenesis. 2011 Dec;32(12):1749-57. Pubmed
29. Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification
    Antalis CJ, Uchida A, Buhman KK, Siddiqui RA.
    Clin Exp Metastasis. 2011 Dec;28(8):733-41. Pubmed
30. Definition of a FoxA1 Cistrome That Is Crucial for G(1) to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer
    Zhang C, Wang L, Wu D, Chen H, Chen Z, Thomas-Ahner JM, Zynger DL, Eeckhoute J, Yu J, Luo J, Brown M, Clinton SK, Nephew KP, Huang TH, Li W, Wang Q.
    Cancer Res. 2011 Nov 1;71(21):6738-48. Pubmed
31. NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines
    Tsofack SP, Garand C, Sereduk C, Chow D, Aziz M, Guay D, Yin HH, Lebel M.
    Mol Cancer. 2011 Nov 25;10:145. Pubmed
32. DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter
    Han H, Cortez CC, Yang X, Nichols PW, Jones PA, Liang G.
    Hum Mol Genet. 2011 Nov 15;20(22):4299-310. Pubmed
33. Role of Pirh2 in Mediating the Regulation of p53 and c-Myc
    Hakem A, Bohgaki M, Lemmers B, Tai E, Salmena L, Matysiak-Zablocki E, Jung YS, Karaskova J, Kaustov L, Duan S, Madore J, Boutros P, Sheng Y, Chesi M, Bergsagel PL, Perez-Ordonez B, Mes-Masson AM, Penn L, Squire J, Chen X, Jurisica I, Arrowsmith C, Sanchez O, Benchimol S, Hakem R.
    PLoS Genet. 2011 Nov;7(11):e1002360. Pubmed
34. IL30-A novel anti-inflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury.
    Dibra D, Cutrera J, Xia X, Kallakury B, Mishra L, Li S.
    Hepatology. 2011 Nov 22. Pubmed
35. Decorin Antagonizes IGF Receptor I (IGF-IR) Function by Interfering with IGF-IR Activity and Attenuating Downstream Signaling
    Iozzo RV, Buraschi S, Genua M, Xu SQ, Solomides CC, Peiper SC, Gomella LG, Owens RC, Morrione A.
    J Biol Chem. 2011 Oct 7;286(40):34712-21. Pubmed
36. Molecular Characterization of the Tumor-Suppressive Function of Nischarin in Breast Cancer
    Baranwal S, Wang Y, Rathinam R, Lee J, Jin L, McGoey R, Pylayeva Y, Giancotti F, Blobe GC, Alahari SK.
    J Natl Cancer Inst. 2011 Oct 19;103(20):1513-28. Pubmed
37. An NF-kappa B p65-cIAP2 link is necessary for mediating resistance to TNF-alpha induced cell death in gliomas
    Zhao X, Laver T, Hong SW, Twitty GB Jr, Devos A, Devos M, Benveniste EN, Nozell SE.
    J Neurooncol. 2011 May;102(3):367-81. Pubmed
38. Critical role of the nucleolus in activation of the p53-dependent postmitotic checkpoint.
    Tsuchiya M, Katagiri N, Kuroda T, Kishimoto H, Nishimura K, Kumazawa T, Iwasaki N, Kimura K, Yanagisawa J.
    Biochem Biophys Res Commun. 2011 Apr 8;407(2):378-82. Pubmed
39. Prognostic Significance of TRIM24/TIF-1 alpha Gene Expression in Breast Cancer
    Chambon M, Orsetti B, Berthe ML, Bascoul-Mollevi C, Rodriguez C, Duong V, Gleizes M, Thénot S, Bibeau F, Theillet C, Cavaillès V.
    Am J Pathol. 2011 Apr;178(4):1461-9. Pubmed
40. RPN1, a new reference gene for quantitative data normalization in lung and kidney cancer
    Krasnov GS, Oparina NIu, Dmitriev AA, Kudriavtsev AV, Anedchenko EA, Kondrat'eva TT, Zabarovskii ER, Senchenko VN.
    Mol Biol (Mosk). 2011 Mar-Apr;45(2):238-48. Pubmed
41. In vitro and in vivo chemosensitizing activity of LFM-A13, a dual-function inhibitor of Bruton's tyrosine kinase and polo-like kinases, against human leukemic B-cell precursors
    Uckun F, Dibirdik I, Sarkissian A, Qazi S.
    Arzneimittelforschung. 2011;61(4):252-9. Pubmed
42. Prediction of human protein-protein interaction by a mixed Bayesian model and its application to exploring underlying cancer-related pathway crosstalk
    Xu Y, Hu W, Chang Z, Duanmu H, Zhang S, Li Z, Li Z, Yu L, Li X.
    J R Soc Interface. 2011 Apr 6;8(57):555-67. Pubmed
43. An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells
    Garand C, Guay D, Sereduk C, Chow D, Tsofack SP, Langlois M, Perreault E, Yin HH, Lebel M.
    Cancer Sci. 2011 Jul;102(7):1410-7. Pubmed
44. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer
    Kim JH, Dhanasekaran SM, Prensner JR, Cao X, Robinson D, Kalyana-Sundaram S, Huang C, Shankar S, Jing X, Iyer M, Hu M, Sam L, Grasso C, Maher CA, Palanisamy N, Mehra R, Kominsky HD, Siddiqui J, Yu J, Qin ZS, Chinnaiyan AM.
    Genome Res. 2011 Jul;21(7):1028-41. Pubmed
45. A pharmacogenomic method for individualized prediction of drug sensitivity
    Cohen AL, Soldi R, Zhang H, Gustafson AM, Wilcox R, Welm BE, Chang JT, Johnson E, Spira A, Jeffrey SS, Bild AH.
    Mol Syst Biol. 2011 Jul 19;7:513. Pubmed
46. Sds22/PP1 links epithelial integrity and tumor suppression via regulation of myosin II and JNK signaling
    Jiang Y, Scott KL, Kwak SJ, Chen R, Mardon G.
    Oncogene. 2011 Jul 21;30(29):3248-60. Pubmed
47. MDM2 interacts with NME2 (non-metastatic cells 2, protein) and suppresses the ability of NME2 to negatively regulate cell motility
    Polanski R, Maguire M, Nield PC, Jenkins RE, Park BK, Krawczynska K, Devling T, Ray-Sinha A, Rubbi CP, Vlatkovic N, Boyd MT.
    Carcinogenesis. 2011 Aug;32(8):1133-42. Pubmed
48. Proteomics revisits the cancer metabolome
    Hu H, Deng C, Yang T, Dong Q, Chen Y, Nice EC, Huang C, Wei Y.
    Expert Rev Proteomics. 2011 Aug;8(4):505-33. Pubmed
49. Identification of Guanylate-Binding Protein 1 as a Potential Oral Cancer Marker Involved in Cell Invasion Using Omics-Based Analysis
    Yu CJ, Chang KP, Chang YJ, Hsu CW, Liang Y, Yu JS, Chi LM, Chang YS, Wu CC.
    J Proteome Res. 2011 Aug 5;10(8):3778-88. Pubmed
50. Loss of VOPP1 overexpression in squamous carcinoma cells induces apoptosis through oxidative cellular injury
    Baras AS, Solomon A, Davidson R, Moskaluk CA.
    Lab Invest. 2011 Aug;91(8):1170-80. Pubmed
51. KIAA0101 Interacts with BRCA1 and Regulates Centrosome Number
    Kais Z, Barsky SH, Mathsyaraja H, Zha A, Ransburgh DJ, He G, Pilarski RT, Shapiro CL, Huang K, Parvin JD.
    Mol Cancer Res. 2011 Aug;9(8):1091-9. Pubmed
52. FHIT Gene and Flanking Region on Chromosome 3p are Subjected to Extensive Allelic Loss in Egyptian Breast Cancer Patients
    Ismail HM, Medhat AM, Karim AM, Zakhary NI.
    Mol Carcinog. 2011 Aug;50(8):625-34. Pubmed
53. Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER-) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors
    Galoian KA, Temple TH, Galoyan A.
    Tumour Biol. 2011 Aug;32(4):745-51. Pubmed
54. Novel Molecular Targets of Azadirachta indica Associated with Inhibition of Tumor Growth in Prostate Cancer
    Mahapatra S, Karnes RJ, Holmes MW, Young CY, Cheville JC, Kohli M, Klee EW, Tindall DJ, Donkena KV.
    AAPS J. 2011 Sep;13(3):365-77. Pubmed
55. Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity
    Wyman SK, Knouf EC, Parkin RK, Fritz BR, Lin DW, Dennis LM, Krouse MA, Webster PJ, Tewari M.
    Genome Res. 2011 Sep;21(9):1450-61. Pubmed
56. Human Hepatic Cancer Stem Cells Are Characterized by Common Stemness Traits and Diverse Oncogenic Pathways
    Marquardt JU, Raggi C, Andersen JB, Seo D, Avital I, Geller D, Lee YH, Kitade M, Holczbauer A, Gillen MC, Conner EA, Factor VM, Thorgeirsson SS.
    Hepatology. 2011 May 26. Pubmed
57. hSav1 interacts with HAX1 and attenuates its anti-apoptotic effects in MCF-7 breast cancer cells
    Luo X, Li Z, Li X, Wang G, Liu W, Dong S, Cai S, Tao D, Yan Q, Wang J, Leng Y, Gong J, Hu J.
    Int J Mol Med. 2011 Sep;28(3):349-55. Pubmed
58. Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors
    Leali D, Alessi P, Coltrini D, Ronca R, Corsini M, Nardo G, Indraccolo S, Presta M.
    Mol Cancer Ther. 2011 Sep;10(9):1600-10. Pubmed
59. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
    Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharfi H, Sasaki AT, Anastasiou D, Mullarky E, Vokes NI, Sasaki M, Beroukhim R, Stephanopoulos G, Ligon AH, Meyerson M, Richardson AL, Chin L, Wagner G, Asara JM, Brugge JS, Cantley LC, Vander Heiden MG.
    Nat Genet. 2011 Jul 31;43(9):869-74. Pubmed
60. Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen
    Wang Q, Li DC, Li ZF, Liu CX, Xiao YM, Zhang B, Li XD, Zhao J, Chen LP, Xing XM, Tang SF, Lin YC, Lai YD, Yang P, Zeng JL, Xiao Q, Zeng XW, Lin ZN, Zhuang ZX, Zhuang SM, Chen W.
    Oncogene. 2011 Sep 8;30(36):3875-86. Pubmed
61. Chemical class-specific gene expression changes in the zebrafish embryo after exposure to glycol ether alkoxy acids and 1,2,4-triazole antifungals
    Hermsen SA, Pronk TE, van den Brandhof EJ, van der Ven LT, Piersma AH.
    Reprod Toxicol. 2011 Sep;32(2):245-52. Pubmed
62. Gel-based proteomics of liver cancer progression in rat
    Albrethsen J, Miller LM, Novikoff PM, Angeletti RH.
    Biochim Biophys Acta. 2011 Oct;1814(10):1367-76. Pubmed
63. Integrative computational biology for cancer research
    Fortney K, Jurisica I.
    Hum Genet. 2011 Oct;130(4):465-81. Pubmed
64. The Estrogen-Regulated Transcription Factor PITX1 Coordinates Gene-Specific Regulation by Estrogen Receptor-Alpha in Breast Cancer Cells
    Stender JD, Stossi F, Funk CC, Charn TH, Barnett DH, Katzenellenbogen BS.
    Mol Endocrinol. 2011 Oct;25(10):1699-709. Pubmed
65. HAX-1: A Family of Apoptotic Regulators in Health and Disease
    Yap SV, Koontz JM, Kontrogianni-Konstantopoulos A.
    J Cell Physiol. 2011 Nov;226(11):2752-61. Pubmed
66. Exposure of Jurkat cells to bis (tri-n-butyltin) oxide (TBTO) induces transcriptomics changes indicative for ER- and oxidative stress, T cell activation and apoptosis
    Katika MR, Hendriksen PJ, van Loveren H, Peijnenburg A.
    Toxicol Appl Pharmacol. 2011 Aug 1;254(3):311-22. Pubmed
67. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
    Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, Sethumadhavan S, Woo HK, Jang HG, Jha AK, Chen WW, Barrett FG, Stransky N, Tsun ZY, Cowley GS, Barretina J, Kalaany NY, Hsu PP, Ottina K, Chan AM, Yuan B, Garraway LA, Root DE, Mino-Kenudson M, Brachtel EF, Driggers EM, Sabatini DM.
    Nature. 2011 Aug 18;476(7360):346-50. Pubmed
68. Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
    Ni M, Chen Y, Lim E, Wimberly H, Bailey ST, Imai Y, Rimm DL, Liu XS, Brown M.
    Cancer Cell. 2011 Jul 12;20(1):119-31. Pubmed
69. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
    Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW.
    Nature. 2011 Jun 8;475(7355):222-5. Pubmed
70. Metabolomic Profiling Reveals a Role for Androgen in Activating Amino Acid Metabolism and Methylation in Prostate Cancer Cells
    Putluri N, Shojaie A, Vasu VT, Nalluri S, Vareed SK, Putluri V, Vivekanandan-Giri A, Byun J, Pennathur S, Sana TR, Fischer SM, Palapattu GS, Creighton CJ, Michailidis G, Sreekumar A.
    PLoS One. 2011;6(7):e21417. Pubmed
71. A Systems Biology-Based Classifier for Hepatocellular Carcinoma Diagnosis
    Zhang Y, Wang S, Li D, Zhnag J, Gu D, Zhu Y, He F.
    PLoS One. 2011;6(7):e22426. Pubmed
72. Integrative Network Biology: Graph Prototyping for Co-Expression Cancer Networks
    Kugler KG, Mueller LA, Graber A, Dehmer M.
    PLoS One. 2011;6(7):e22843. Pubmed
73. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
    Massie CE, Lynch A, Ramos-Montoya A, Boren J, Stark R, Fazli L, Warren A, Scott H, Madhu B, Sharma N, Bon H, Zecchini V, Smith DM, Denicola GM, Mathews N, Osborne M, Hadfield J, Macarthur S, Adryan B, Lyons SK, Brindle KM, Griffiths J, Gleave ME, Rennie PS, Neal DE, Mills IG.
    EMBO J. 2011 May 20;30(13):2719-33. Pubmed
74. Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors
    Daves MH, Hilsenbeck SG, Lau CC, Man TK.
    BMC Med Genomics. 2011 Jul 7;4:56. Pubmed
75. Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis
    Fang F, Turcan S, Rimner A, Kaufman A, Giri D, Morris LG, Shen R, Seshan V, Mo Q, Heguy A, Baylin SB, Ahuja N, Viale A, Massague J, Norton L, Vahdat LT, Moynahan ME, Chan TA.
    Sci Transl Med. 2011 Mar 23;3(75):75ra25. Pubmed
76. General Approach to Identifying Potential Targets for Cancer Imaging by Integrated Bioinformatics Analysis of Publicly Available Genomic Profiles
    Yang Y, Adelstein SJ, Kassis AI.
    Mol Imaging. 2011 Apr;10(2):123-34. Pubmed
77. Inhibition of HIF Prolyl Hydroxylase-2 Blocks Tumor Growth in Mice through the Antiproliferative Activity of TGF beta
    Ameln AK, Muschter A, Mamlouk S, Kalucka J, Prade I, Franke K, Rezaei M, Poitz DM, Breier G, Wielockx B.
    Cancer Res. 2011 May 1;71(9):3306-16. Pubmed
78. Large-scale analysis of expression signatures reveals hidden links among diverse cellular processes
    Ge SX.
    BMC Syst Biol. 2011 May 29;5:87. Pubmed
79. Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy
    Shiraishi T, Terada N, Zeng Y, Suyama T, Luo J, Trock B, Kulkarni P, Getzenberg RH.
    J Transl Med. 2011 Sep 14;9:153. Pubmed
80. NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor
    Mori T, Ikeda DD, Fukushima T, Takenoshita S, Kochi H.
    Cell Cycle. 2011 Oct 1;10(19):3284-99. Pubmed
81. MicroRNA expression profiling in human Barrett's carcinogenesis
    Fassan M, Volinia S, Palatini J, Pizzi M, Baffa R, De Bernard M, Battaglia G, Parente P, Croce CM, Zaninotto G, Ancona E, Rugge M.
    Int J Cancer. 2011 Oct 1;129(7):1661-70. Pubmed
82. p62 Is a Key Regulator of Nutrient Sensing in the mTORC1 Pathway
    Duran A, Amanchy R, Linares JF, Joshi J, Abu-Baker S, Porollo A, Hansen M, Moscat J, Diaz-Meco MT.
    Mol Cell. 2011 Oct 7;44(1):134-46. Pubmed
83. Faithful Markers of Circulating Cancer Stem Cells: Is CD133 Sufficient for Validation in Clinics?
    Crea F, Fornaro L, Masi G, Falcone A, Danesi R, Farrar W.
    J Clin Oncol. 2011 Sep 1;29(25):3487-8; author reply 3488-90. Pubmed
84. Roles of COP9 signalosome in cancer
    Lee MH, Zhao R, Phan L, Yeung SC.
    Cell Cycle. 2011 Sep 15;10(18):3057-66. Pubmed
85. Cellular Model of Warburg Effect Identifies Tumor Promoting Function of UCP2 in Breast Cancer and Its Suppression by Genipin
    Ayyasamy V, Owens KM, Desouki MM, Liang P, Bakin A, Thangaraj K, Buchsbaum DJ, LoBuglio AF, Singh KK.
    PLoS One. 2011;6(9):e24792. Pubmed
86. In Silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer
    Kaur M, MacPherson CR, Schmeier S, Narasimhan K, Choolani M, Bajic VB.
    BMC Syst Biol. 2011 Sep 19;5:144. Pubmed
87. An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737
    Al-Harbi S, Hill BT, Mazumder S, Singh K, Devecchio J, Choudhary G, Rybicki LA, Kalaycio M, Maciejewski JP, Houghton JA, Almasan A.
    Blood. 2011 Sep 29;118(13):3579-90. Pubmed
88. [Identification of proteins overexpressed in malignant gastric tumors: comparison of the results of 2-De and bioinformatics search].
    Grigor'eva ES, Bukurova IuA, Krasnov GS, Afanas'ev SG, Cherdyntseva NV, Tuzikov SA, Choĭnzonov EL, Karpov VL, Lisitsyn NA, Beresten' SF.
    Mol Biol (Mosk). 2011 Jul-Aug;45(4):738-43. Russian. Pubmed
89. Mining the malignant Ascites Proteome for Pancreatic Cancer Biomarkers.
    Kosanam H, Makawita S, Judd B, Newman A, Diamandis EP.
    Proteomics. 2011 Sep 19. Pubmed
90. Anterior Gradient 2 Overexpression in Lung Adenocarcinoma.
    Pizzi M, Fassan M, Balistreri M, Galligioni A, Rea F, Rugge M.
    Appl Immunohistochem Mol Morphol. 2011 Jul 15. Pubmed
91. [Novel reference gene RPN1 for normalization of quantitative data in lung and kidney cancer].
    Krasnov GS, Oparina NIu, Dmitriev AA, Kudriavtsev AV, Anedchenko EA, Kondrat'eva TT, Zabarovskiĭ ER, Senchenko VN.
    Mol Biol (Mosk). 2011 Mar-Apr;45(2):238-48. Russian. Pubmed
92. Increased expression of DNA repair genes in invasive human pancreatic cancer cells.
    Mathews LA, Cabarcas SM, Hurt EM, Zhang X, Jaffee EM, Farrar WL.
    Pancreas. 2011 Jul;40(5):730-9. Pubmed
93. Clinical validation of colorectal cancer biomarkers identified from bioinformatics analysis of public expression data.
    Jung Y, Lee S, Choi HS, Kim SN, Lee E, Shin Y, Seo J, Kim B, Jung Y, Kim WK, Chun HK, Lee WY, Kim J.
    Clin Cancer Res. 2011 Feb 15;17(4):700-9. Pubmed
94. Transducin ß-like protein 1 recruits nuclear factor KB to the target gene promoter for transcriptional activation.
    Ramadoss S, Li J, Ding X, Al Hezaimi K, Wang CY.
    Mol Cell Biol. 2011 Mar;31(5):924-34. Pubmed
95. Categorical meta-analysis of Osteopontin as a clinical cancer marker.
    Weber GF, Lett GS, Haubein NC.
    Oncol Rep. 2011 Feb;25(2):433-41. Pubmed
96. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
    Arendt LM, Rugowski DE, Grafwallner-Huseth TA, Garcia-Barchino MJ, Rui H, Schuler LA.
    Breast Cancer Res. 2011 Jan 28;13(1):R11. Pubmed
97. JAG2 induction in hypoxic tumor cells alters Notch signaling and enhances endothelial cell tube formation.
    Pietras A, von Stedingk K, Lindgren D, Påhlman S, Axelson H.
    Mol Cancer Res. 2011 May;9(5):626-36. Pubmed
98. An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-αinduced cell death in gliomas.
    Zhao X, Laver T, Hong SW, Twitty GB Jr, Devos A, Devos M, Benveniste EN, Nozell SE.
    J Neurooncol. 2011 May;102(3):367-81. Pubmed
99. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.
    Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, Walker K, Zelenika D, Gut I, Heath S, Palles C, Coupland B, Broderick P, Schoemaker M, Jones M, Williamson J, Chilcott-Burns S, Tomczyk K, Simpson G, Jacobs KB, Chanock SJ, Hunter DJ, Tomlinson IP, Swerdlow A, Ashworth A, Ross G, dos Santos Silva I, Lathrop M, Houlston RS, Peto J.
    J Natl Cancer Inst. 2011 Mar 2;103(5):425-35. Pubmed
100. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer.
     Di Micco R, Sulli G, Dobreva M, Liontos M, Botrugno OA, Gargiulo G, dal Zuffo R, Matti V, d'Ario G, Montani E, Mercurio C, Hahn WC, Gorgoulis V, Minucci S, d'Adda di Fagagna F.
     Nat Cell Biol. 2011 Mar;13(3):292-302. Pubmed
101. Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays.
     Babel I, Barderas R, Diaz-Uriarte R, Moreno V, Suarez A, Fernandez-Aceñero MJ, Salazar R, Capellá G, Casal JI.
     Mol Cell Proteomics. 2011 Mar;10(3):M110.001784. Pubmed
102. Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling.
     Lisse TS, Liu T, Irmler M, Beckers J, Chen H, Adams JS, Hewison M.
     FASEB J. 2011 Mar;25(3):937-47. Pubmed
103. Mad2 Is a Critical Mediator of the Chromosome Instability Observed upon Rb and p53 Pathway Inhibition.
     Schvartzman JM, Duijf PH, Sotillo R, Coker C, Benezra R.
     Cancer Cell. 2011 Jun 14;19(6):701-14. Pubmed
104. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.
     King ER, Tung CS, Tsang YT, Zu Z, Lok GT, Deavers MT, Malpica A, Wolf JK, Lu KH, Birrer MJ, Mok SC, Gershenson DM, Wong KK.
     Am J Surg Pathol. 2011 Jun;35(6):904-12. Pubmed
105. Ubiquitously Expressed Hematological and Neurological Expressed 1 Downregulates Akt-Mediated GSK3β Signaling, and Its Knockdown Results in Deregulated G2/M Transition in Prostate Cells.
     Varisli L, Gonen-Korkmaz C, Debelec-Butuner B, Erbaykent-Tepedelen B, Muhammed HS, Bogurcu N, Saatcioglu F, Korkmaz KS.
     DNA Cell Biol. 2011 Jun;30(6):419-29. Pubmed
106. The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer.
     Privette Vinnedge LM, McClaine R, Wagh PK, Wikenheiser-Brokamp KA, Waltz SE, Wells SI.
     Oncogene. 2011 Jun 16;30(24):2741-52. Pubmed
107. CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression.
     Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L, Bliskovsky V, Mock B, Ried T, London WB, Maris J, Khan J, Thiele CJ.
     Cell Death Differ. 2011 Jul;18(7):1174-83. Pubmed
108. Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation.
     Seethala RR, Cieply K, Barnes EL, Dacic S.
     Arch Pathol Lab Med. 2011 Jan;135(1):123-30. Pubmed
109. Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.
     Vainio P, Gupta S, Ketola K, Mirtti T, Mpindi JP, Kohonen P, Fey V, Perälä M, Smit F, Verhaegh G, Schalken J, Alanen KA, Kallioniemi O, Iljin K.
     Am J Pathol. 2011 Feb;178(2):525-36. Pubmed
110. SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63.
     Bornstein C, Brosh R, Molchadsky A, Madar S, Kogan-Sakin I, Goldstein I, Chakravarti D, Flores ER, Goldfinger N, Sarig R, Rotter V.
     Mol Cell Biol. 2011 Apr;31(8):1679-89. Pubmed
111. SMOC1 is a tenascin-C interacting protein over-expressed in brain tumors.
     Brellier F, Ruggiero S, Zwolanek D, Martina E, Hess D, Brown-Luedi M, Hartmann U, Koch M, Merlo A, Lino M, Chiquet-Ehrismann R.
     Matrix Biol. 2011 Apr;30(3):225-33. Pubmed
112. PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis.
     Fassan M, Pizzi M, Giacomelli L, Mescoli C, Ludwig K, Pucciarelli S, Rugge M.
     Virchows Arch. 2011 Apr;458(4):413-9. Pubmed
113. Identification of PITX1 as a TERT suppressor gene located on human chromosome 5.
     Qi DL, Ohhira T, Fujisaki C, Inoue T, Ohta T, Osaki M, Ohshiro E, Seko T, Aoki S, Oshimura M, Kugoh H.
     Mol Cell Biol. 2011 Apr;31(8):1624-36. Pubmed
114. c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase.
     Szabo R, Rasmussen AL, Moyer AB, Kosa P, Schafer JM, Molinolo AA, Gutkind JS, Bugge TH.
     Oncogene. 2011 Apr 28;30(17):2003-16. Pubmed
115. Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.
     Vlatkovic N, El-Fert A, Devling T, Ray-Sinha A, Gore DM, Rubbi CP, Dodson A, Jones AS, Helliwell TR, Jones TM, Boyd MT.
     Cancer. 2011 Jan 10. Pubmed
116. MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome.
     Wang QF, Wu G, Mi S, He F, Wu J, Dong J, Luo RT, Mattison R, Kaberlein JJ, Prabhakar S, Ji H, Thirman MJ.
     Blood. 2011 Jun 23;117(25):6895-905. Pubmed
117. LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer.
     Thomasson M, Wang B, Hammarsten P, Dahlman A, Persson JL, Josefsson A, Stattin P, Granfors T, Egevad L, Henriksson R, Bergh A, Hedman H.
     Int J Cancer. 2011 Jun 15;128(12):2843-52. Pubmed
118. Exploiting prior knowledge and gene distances in the analysis of tumor expression profiles with extended Hidden Markov Models.
     Seifert M, Strickert M, Schliep A, Grosse I.
     Bioinformatics. 2011 Jun 15;27(12):1645-52. Pubmed
119. SULFs in human neoplasia: implication as progression and prognosis factors.
     Bret C, Moreaux J, Schved JF, Hose D, Klein B.
     J Transl Med. 2011 May 21;9:72. Pubmed
120. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.
     Brenner JC, Ateeq B, Li Y, Yocum AK, Cao Q, Asangani IA, Patel S, Wang X, Liang H, Yu J, Palanisamy N, Siddiqui J, Yan W, Cao X, Mehra R, Sabolch A, Basrur V, Lonigro RJ, Yang J, Tomlins SA, Maher CA, Elenitoba-Johnson KS, Hussain M, Navone NM, Pienta KJ, Varambally S, Feng FY, Chinnaiyan AM.
     Cancer Cell. 2011 May 17;19(5):664-78. Pubmed
121. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis.
     Shi L, Sun L, Li Q, Liang J, Yu W, Yi X, Yang X, Li Y, Han X, Zhang Y, Xuan C, Yao Z, Shang Y.
     Proc Natl Acad Sci U S A. 2011 May 3;108(18):7541-6. Pubmed
122. RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis.
     Funasaka T, Nakano H, Wu Y, Hashizume C, Gu L, Nakamura T, Wang W, Zhou P, Moore MA, Sato H, Wong RW.
     Cell Cycle. 2011 May 1;10(9):1456-67. Pubmed
123. Neighbor of Punc E11, a novel oncofetal marker for hepatocellular carcinoma.
     Marquardt JU, Quasdorff M, Varnholt H, Curth HM, Mesghenna S, Protzer U, Goeser T, Nierhoff D.
     Int J Cancer. 2011 May 15;128(10):2353-63. Pubmed
124. Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFβ.
     Ameln AK, Muschter A, Mamlouk S, Kalucka J, Prade I, Franke K, Rezaei M, Poitz DM, Breier G, Wielockx B.
     Cancer Res. 2011 May 1;71(9):3306-16. Pubmed
125. Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells.
     Little AS, Balmanno K, Sale MJ, Newman S, Dry JR, Hampson M, Edwards PA, Smith PD, Cook SJ.
     Sci Signal. 2011 Mar 29;4(166):ra17. Pubmed
126. Recombinant human CD19-ligand protein as a potent anti-leukaemic agent.
     Uckun FM, Sun L, Qazi S, Ma H, Ozer Z.
     Br J Haematol. 2011 Apr;153(1):15-23. Pubmed
127. RNA polymerase III transcription in cancer: the BRF2 connection.
     Cabarcas S, Schramm L.
     Mol Cancer. 2011 Apr 25;10:47. Pubmed
128. FOXQ1 regulates epithelial-mesenchymal transition in human cancers.
     Qiao Y, Jiang X, Lee ST, Karuturi RK, Hooi SC, Yu Q.
     Cancer Res. 2011 Apr 15;71(8):3076-86. Pubmed
129. BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer.
     Crea F, Duhagon Serrat MA, Hurt EM, Thomas SB, Danesi R, Farrar WL.
     Int J Cancer. 2011 Apr 15;128(8):1946-54. Pubmed
130. An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer.
     Cui J, Chen Y, Chou WC, Sun L, Chen L, Suo J, Ni Z, Zhang M, Kong X, Hoffman LL, Kang J, Su Y, Olman V, Johnson D, Tench DW, Amster IJ, Orlando R, Puett D, Li F, Xu Y.
     Nucleic Acids Res. 2011 Mar;39(4):1197-207. Pubmed
131. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development.
     Kawazu M, Saso K, Tong KI, McQuire T, Goto K, Son DO, Wakeham A, Miyagishi M, Mak TW, Okada H.
     PLoS One. 2011 Mar 18;6(3):e17830. Pubmed
132. Gene-expression signatures can distinguish gastric cancer grades and stages.
     Cui J, Li F, Wang G, Fang X, Puett JD, Xu Y.
     PLoS One. 2011 Mar 18;6(3):e17819. Pubmed
133. Making sense of cancer genomic data.
     Chin L, Hahn WC, Getz G, Meyerson M.
     Genes Dev. 2011 Mar 15;25(6):534-55. Pubmed
134. Differential expression of CHL1 gene during development of major human cancers.
     Senchenko VN, Krasnov GS, Dmitriev AA, Kudryavtseva AV, Anedchenko EA, Braga EA, Pronina IV, Kondratieva TT, Ivanov SV, Zabarovsky ER, Lerman MI.
     PLoS One. 2011 Mar 7;6(3):e15612. Pubmed
135. Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer.
     Corpet A, De Koning L, Toedling J, Savignoni A, Berger F, Lemaître C, O'Sullivan RJ, Karlseder J, Barillot E, Asselain B, Sastre-Garau X, Almouzni G.
     EMBO J. 2011 Feb 2;30(3):480-93. Pubmed
136. The effects of deoxynivalenol on gene expression in the murine thymus.
     van Kol SW, Hendriksen PJ, van Loveren H, Peijnenburg A.
     Toxicol Appl Pharmacol. 2011 Feb 1;250(3):299-311. Pubmed
137. Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer.
     Tabach Y, Kogan-Sakin I, Buganim Y, Solomon H, Goldfinger N, Hovland R, Ke XS, Oyan AM, Kalland KH, Rotter V, Domany E.
     PLoS One. 2011 Jan 31;6(1):e14632. Pubmed
138. Transducer of Cdc42-dependent actin assembly promotes epidermal growth factor-induced cell motility and invasiveness.
     Hu J, Mukhopadhyay A, Craig AW.
     J Biol Chem. 2011 Jan 21;286(3):2261-72. Pubmed
139. Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas.
     Savaskan NE, Seufert S, Hauke J, Tränkle C, Eyüpoglu IY, Hahnen E.
     Oncogene. 2011 Jan 6;30(1):43-53. Pubmed
140. BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients.
     De Carvalho DD, Binato R, Pereira WO, Leroy JM, Colassanti MD, Proto-Siqueira R, Bueno-Da-Silva AE, Zago MA, Zanichelli MA, Abdelhay E, Castro FA, Jacysyn JF, Amarante-Mendes GP.
     Oncogene. 2011 Jan 13;30(2):223-33. Pubmed
141. Genome-wide analysis of transcriptional reprogramming in mouse models of acute myeloid leukaemia.
     Bonadies N, Foster SD, Chan WI, Kvinlaug BT, Spensberger D, Dawson MA, Spooncer E, Whetton AD, Bannister AJ, Huntly BJ, Göttgens B.
     PLoS One. 2011 Jan 28;6(1):e16330. Pubmed